Bromfenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) primarily indicated for the treatment of ocular inflammation and pain, specifically for use before and after cataract surgery. To support… Read more
![Chemical structure of (12-Oxo-5,6,11,12-tetrahydrobenzo[6,7]azepino[4,3-b]indole-4,10-diyl)bis((4-bromophenyl)methanone)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1644279-16-2-12-Oxo-561112-tetrahydrobenzo67azepino43-bindole-410-diylbis4-bromophenylmethanone.png&w=3840&q=75)




Bromfenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) primarily indicated for the treatment of ocular inflammation and pain, specifically for use before and after cataract surgery. To support rigorous analytical testing and quality control protocols, this collection provides high-quality reference standards for the active pharmaceutical ingredient, alongside a comprehensive selection of process-related impurities, degradation products, and metabolites. Pharmaceutical laboratories utilize these materials for impurity profiling, method validation, and stability testing to ensure compliance with regulatory standards. By offering both pharmacopeial and non-pharmacopeial impurities, including benzoic acid derivatives, lactam forms, and dimers, this category facilitates accurate identification and quantification. Additionally, stable isotope-labelled compounds are available to serve as reliable internal standards in mass spectrometry-based assays, ensuring precise analysis throughout the drug development and manufacturing lifecycle.